Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1903 1
1913 1
1938 1
1941 1
1942 2
1943 1
1944 4
1945 6
1946 19
1947 41
1948 20
1949 22
1950 30
1951 46
1952 75
1953 252
1954 188
1955 211
1956 125
1957 71
1958 70
1959 70
1960 82
1961 106
1962 138
1963 114
1964 136
1965 183
1966 332
1967 447
1968 125
1969 461
1970 1026
1971 3083
1972 4682
1973 6321
1974 8217
1975 7261
1976 7279
1977 7276
1978 7505
1979 7130
1980 5558
1981 4763
1982 5392
1983 5843
1984 7009
1985 7254
1986 7507
1987 7946
1988 8903
1989 11130
1990 12503
1991 13441
1992 14410
1993 14552
1994 15115
1995 16407
1996 17991
1997 18978
1998 19844
1999 20283
2000 20551
2001 20170
2002 22480
2003 25954
2004 28139
2005 31837
2006 35894
2007 40828
2008 43704
2009 45442
2010 46997
2011 50602
2012 54835
2013 57167
2014 58438
2015 59578
2016 58673
2017 57736
2018 58153
2019 60472
2020 60067
2021 55583
2022 41700
2023 35460
2024 34882
2025 82

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,257,325 results

Results by year

Filters applied: . Clear all
Page 1
Artificial Intelligence for Drug Toxicity and Safety.
Basile AO, Yahi A, Tatonetti NP. Basile AO, et al. Trends Pharmacol Sci. 2019 Sep;40(9):624-635. doi: 10.1016/j.tips.2019.07.005. Epub 2019 Aug 2. Trends Pharmacol Sci. 2019. PMID: 31383376 Free PMC article. Review.
Adverse drug reactions.
Coleman JJ, Pontefract SK. Coleman JJ, et al. Clin Med (Lond). 2016 Oct;16(5):481-485. doi: 10.7861/clinmedicine.16-5-481. Clin Med (Lond). 2016. PMID: 27697815 Free PMC article. Review.
A Pharmacovigilance Florilegium.
Hauben M. Hauben M. Clin Ther. 2024 Jul;46(7):520-523. doi: 10.1016/j.clinthera.2024.06.011. Epub 2024 Jul 19. Clin Ther. 2024. PMID: 39030077 No abstract available.
Drug Safety Evaluation in China.
Li L, Yin J. Li L, et al. Curr Allergy Asthma Rep. 2019 Jul 18;19(9):39. doi: 10.1007/s11882-019-0872-4. Curr Allergy Asthma Rep. 2019. PMID: 31321555 Review.
Organoids in modelling infectious diseases.
Shpichka A, Bikmulina P, Peshkova M, Heydari Z, Kosheleva N, Vosough M, Timashev P. Shpichka A, et al. Drug Discov Today. 2022 Jan;27(1):223-233. doi: 10.1016/j.drudis.2021.08.005. Epub 2021 Aug 18. Drug Discov Today. 2022. PMID: 34418577 Review.
Pharmacovigilance: The responsibility of all.
Walsh S. Walsh S. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1681-1682. doi: 10.1111/jdv.20172. J Eur Acad Dermatol Venereol. 2024. PMID: 39177319 No abstract available.
Surveillance and Safety.
Ruff JC. Ruff JC. J Am Dent Assoc. 2020 Oct;151(10):722-723. doi: 10.1016/j.adaj.2020.08.010. J Am Dent Assoc. 2020. PMID: 32979949 Free PMC article. No abstract available.
Postmarketing surveillance.
Vlahović-Palčevski V, Mentzer D. Vlahović-Palčevski V, et al. Handb Exp Pharmacol. 2011;205:339-51. doi: 10.1007/978-3-642-20195-0_17. Handb Exp Pharmacol. 2011. PMID: 21882120
Opening the FDA black box.
Goodman SN, Redberg RF. Goodman SN, et al. JAMA. 2014 Jan 22-29;311(4):361-3. doi: 10.1001/jama.2013.283946. JAMA. 2014. PMID: 24449313 No abstract available.
1,257,325 results
You have reached the last available page of results. Please see the User Guide for more information.